LifeStyle

• 
  Researchers discover anti-inflammatory biological material from gulfweed extract SEOUL -- Sargassum micracanthum, a brown alga that grows naturally on rocks along the coast has been largely ignored because it's not worth using. From its extract, South Korean researchers have discovered a new butenolide derivative that can be used as an anti-inflammatory biological material. About 30 species of Sargassaceae (gulfweed) are native to the sea around the Korean Peninsula, and their active ingredients were found to show anti-inflammatory effects. The extract of 2022-07-08
• 
  Cosmax works with University of Indonesia to develop natural raw materials for cosmetics SEOUL -- Cosmax, a cosmetics original development manufacturer in South Korea, joined hands with the school of pharmacy at the University of Indonesia to develop natural raw materials for cosmetics and carry out a joint study on new products, citing growing demands in the Southeast Asian country for skincare products containing new ingredients. Under a memorandum of agreement signed on July 1, Cosmax said that Indonesian native plants would be extracted, researched and tested f 2022-07-05
• 
  HK inno.N works with GC Cell to develop next-generation cell therapy for solid cancer SEOUL --HK inno.N, a pharmaceutical product maker in South Korea, joined hands with GC Cell to develop next-generation immuno-cancer cell therapy that works well for solid cancer by using HLA-G, a nonclassical protein that acts as a major immune checkpoint. The human leukocyte antigen (HLA) has been shown to be associated with tumor escape in cancers because it causes the immune system to not pay attention to cancer cells. HLA-G has potential utility as a tumor marker due to the lar 2022-07-04
• 
  Hyundai Robotics' quarantine robot uses plasma and UVC LED sterilization. SEOUL -- An autonomous quarantine robot developed by Hyundai Robotics is ready for commercial operation. It can conduct face-to-face quarantine activities in the lobby and passageways of buildings using plasma and ultraviolet-C light-emitting diode (LED) sterilization. Hyundai Robotics, a robot maker affiliated with South Korea's top shipbuilding group, would release its new quarantine robot on July 1. Plasma sterilization removes various harmful bacteria and discharges purified 2022-06-30
• 
  Daewoo shipyard works with university to develop radiated noise reduction technology SEOUL -- Daewoo Shipbuilding & Marine Engineering, a major shipbuilder in South Korea, will carry out a joint study with a national university on technologies to reduce anthropogenic noise that has threatened underwater wildlife, responding to an international campaign to tighten relations on marine environmental protection. Daewoo Shipbuilding & Marine Engineering (DSME) said that its joint research with Mokpo National Maritime University is expected to advance noise pred 2022-06-30
• 
  LG Chem leads project to recover resource in cement production SEOUL -- South Korean cement companies are expanding the use of waste plastic with high bio-mass content as an alternative fuel to reduce greenhouse gas emissions from the heating of limestone, the burning of fossil fuels, and a chemical process called calcination. Burning waste plastics produces chlorine dust, a byproduct that cannot be recycled. Chlorine components attached to the walls of cement preheaters also reduce the utilization of production facilities. LG Chem tied up wit 2022-06-30
• 
  S. Korea's first homemade COVID-19 vaccine secures final state approval for manufacturing and sales SEOUL -- South Korea's first homemade COVID-19 vaccine developed by SK Bioscience secured final state approval for manufacturing and sales at home and abroad. SK Bioscience will seek to get its vaccine listed by the World Health Organization for emergency use. The Ministry of Food and Drug Safety, a government public health agency, said it has approved the manufacturing and sales of SK Bioscience's vaccine codenamed GBP510 as a condition of submitting the final result repor 2022-06-29
• 
  Silica used for Kolmar Korea's color cosmetics to replace microplastics SEOUL -- Powder formulations containing microplastics are widely used for the soft application of color cosmetics, but research has been conducted to find alternative materials as microscopic plastic particles have become a serious environmental issue that can have devastating effects on ecosystems and human health. Kolmar Korea, a beauty and cosmetics product maker, has developed a technology that replaces microplastics used in color cosmetics with silica, a natural substance Silic 2022-06-29
• 
  CGBIO leads state-funded project to develop new negative pressure wound treatment device SEOUL -- CGBIO, a total healthcare provider in South Korea, has been selected for a state-funded project to develop a new negative pressure wound cleaning and healing device that can regenerate wounds and treat infections at the same time. The project is aimed at enhancing the competitiveness of localized equipment in the global market dominated by foreign companies. Negative pressure wound therapy (NPWT) improves the healing of open nonsurgical wounds using negative pressure for th 2022-06-27
• 
  Researchers propose practical solution to prevent cross-infection while preserving skin naturalness SEOUL -- A COVID-19 pandemic has called for the enhanced hygiene of public facilities. The fear of infection prompted the fast adoption of antibacterial materials such as gloves. Antibacterial films and similar materials were widely used to cover elevator buttons, door handles and other objects that are frequently touched by many random people. However, there has been no practical solution to prevent cross-infection while preserving intrinsic skin naturalness. South Korean and Jap 2022-06-23
• 
  Theragen Bio selected for state project to produce new chips for genomic analysis SEOUL -- Theragen Bio, a genetic analysis service provider, has been selected for a state project to produce advanced chips for genomic analysis that would be used for identifying the genetic causes of common chronic diseases among Korean people. The Korea Disease Control and Prevention Agency (KDCA), a state health body, has launched a "Korean Chip" project to identify the genetic causes of common chronic diseases by collecting information on genetic variation. A genome 2022-06-07
• 
  Yuhan works with research teams to develop new drug platforms based on mRNA SEOUL -- Yuhan, a pharmaceutical and chemical company in South Korea, will push for the development of new drug platform technologies based on messenger ribonucleic acid (mRNA) in cooperation with U.S. and South Koran university research teams. mRNA is a transient intermediator between genes and proteins. It has emerged as a new category of therapeutic agent to prevent and treat various diseases. To function in vivo, mRNA requires safe, effective and stable delivery systems such as 2022-06-07
• 
  State project launched to develop biodegradable marine bioplastic materials using seaweed SEOUL -- South Korea has launched a state project to develop biodegradable marine bioplastic materials using seaweed such as sargassum horneri, a species of brown macroalgae called "devil weed" from China that is detrimental to a foreshore ecosystem and damages sea farms almost every year. Since bioplastics mainly use grain biomass such as corn as raw materials, their production is still insignificant due to economic problems caused by expensive raw materials. The Minis 2022-06-07
• 
  Protected marine creature bred artificially for discharge in river habitat SEOUL -- Clithon retropictum is a protected species of freshwater and brackish water snail with an operculum. It lives in the estuary of a clean river and eats attached algae or organic matter. It is very vulnerable to the deterioration of water quality or changes in the river environment. The Ministry of Oceans and Fisheries designated the bracken as a protected marine creature in 2016 and succeeded in developing artificial proliferation in 2021 for the first time in the world in 2022-06-02
• 
  HK inno.N ties up with domestic company to find new drug candidates using exosome SEOUL -- HK inno.N, a pharmaceutical product maker in South Korea, will find new drug candidates using exosomes for the treatment of chronic diseases and acute respiratory infections in cooperation with a domestic biotechnology company that specializes in therapeutic molecules. Exosomes, which are recognized for their critical role in cell-to-cell communication and transportation, are small vesicles found in nearly all eukaryotic fluids and facilitate a variety of important cellula 2022-05-27
• 
  SK Bioscience delivers first shipment of chickenpox vaccine to Latin America SEOUL -- SK Bioscience has delivered the first shipment of its chickenpox vaccine injection solution, Sky Varicella, as part of a $31.27 million order from an international public health agency that regularly identifies the provisional demand for chickenpox vaccines from member countries in Latin America. Through preliminary bidding, the Pan American Health Organization (PAHO) selects companies with global technology and productivity as chickenpox vaccine providers. SK Bioscience s 2022-05-23
• 
  University team applies genetic tracking system to breed 'low-carbon' cow SEOUL -- Fertilizing feed for beef cattle produces nitrous oxide emissions, a powerful greenhouse gas produced by microbes. Cows burp out large quantities of heat-trapping methane. As a result, beef causes vastly more emissions than most other foods. Various solutions have been studied to lower the carbon footprint of beef and dairy cattle. A research team led by Lee Hak-gyo, a professor of animal life engineering at Jeonbuk National University has acquired a method to distinguish & 2022-05-23
• 
  Axiom founder holds business talks with Boryung's CEO as partners in space project SEOUL -- Kam Ghaffarian, the founder of U.S. space infrastructure developer Axiom Space, has held business talks with Boryung Corp.'s leader during his visit to South Korea as a partner in their joint initiative to advance the next generation of pharmaceutical, bioscience and medtech development in space. The meeting with CEO Jay Kim of Boryung Corp. engaged in pharmaceutical manufacturing, took place on May 17 in Seoul. Boryung has made an unspecified amount of equity investmen 2022-05-19
• 
  Researchers work on alginate mass production to reduce S. Korea's reliance on imports SEOUL -- In an effort to reduce South Korea's heavy reliance on imports, a state marine research body in South Korea will lead a government project to develop technologies for the mass production of alginate, an anionic polymer that occurs naturally in brown algae. Alginates are used as a pharmaceutical or biomedical ingredient or as a compound for advanced biotechnology. Alginic acid is hydrophilic and forms a viscous gum when hydrated. With metals such as sodium and calcium, 2022-05-12
• 
  GI Innovation's GI-101 selected for government-initiated drug development program SEOUL -- GI-101, an immunotherapy agent being developed by South Korea's bio-venture company GI Innovation, has been selected for a government-initiated drug development program to receive financial support at clinical stages. GI Innovation said it would get up to seven billion won ($5.5 million) in research support for two years from the Korea Drug Development Fund (KDDF), which supports the investment, nurture and development of promising drugs. KDDF's move is seen as a 2022-05-09